Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system
Abstract Zebrafish is an established valuable model for understanding the complex in vivo behavior of systemic nanocarrier strategies, their safety profile, and the array of possible compositions. To date, we have explored the possibility of Paclitaxel (PTX) delivery using liposome systems as a prom...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00258-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849705062704611328 |
|---|---|
| author | Andrea Persico Laura Molteni Paride Mantecca Marcelo Kravicz Cinzia Bragato |
| author_facet | Andrea Persico Laura Molteni Paride Mantecca Marcelo Kravicz Cinzia Bragato |
| author_sort | Andrea Persico |
| collection | DOAJ |
| description | Abstract Zebrafish is an established valuable model for understanding the complex in vivo behavior of systemic nanocarrier strategies, their safety profile, and the array of possible compositions. To date, we have explored the possibility of Paclitaxel (PTX) delivery using liposome systems as a promising approach to treating cancer. Despite its benefits, this efficacious anti-cancer drug presents a main adverse effect, such as the onset of chemotherapy-induced peripheral neuropathy (CIPN). Thus, many research efforts are aimed at searching for the resolution or reduction of such problems. Taking advantage of zebrafish embryos, a powerful model for predicting and translating what is observed in humans, we investigated the plain PTX outcomes and compared them to the effects of different liposomes loaded with PTX. Since approximately 70% of human genes have at least one orthologue in zebrafish, studying the molecular mechanisms underlying chemotherapy-induced toxicity and increased oxidative stress becomes easy. First, we used a transgenic model to evaluate the systemic response to different concentrations of PTX, planning the final concentration to be loaded in liposomes, with and without functionalization. Then, we assessed the effects of this promising nanocarrier system at a molecular, histochemical, and behavioral level in reducing the detrimental side effects of the most successful cancer drug. |
| format | Article |
| id | doaj-art-ffeb02e4fe2340689a0ba744e03371ce |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-ffeb02e4fe2340689a0ba744e03371ce2025-08-20T03:16:34ZengNature PortfolioScientific Reports2045-23222025-05-0115111510.1038/s41598-025-00258-1Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier systemAndrea Persico0Laura Molteni1Paride Mantecca2Marcelo Kravicz3Cinzia Bragato4POLARIS Research Center, Department of Earth and Environmental Sciences, University of Milano-BicoccaExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-BicoccaPOLARIS Research Center, Department of Earth and Environmental Sciences, University of Milano-BicoccaSchool of Medicine and Surgery, University of Milano-BicoccaPOLARIS Research Center, Department of Earth and Environmental Sciences, University of Milano-BicoccaAbstract Zebrafish is an established valuable model for understanding the complex in vivo behavior of systemic nanocarrier strategies, their safety profile, and the array of possible compositions. To date, we have explored the possibility of Paclitaxel (PTX) delivery using liposome systems as a promising approach to treating cancer. Despite its benefits, this efficacious anti-cancer drug presents a main adverse effect, such as the onset of chemotherapy-induced peripheral neuropathy (CIPN). Thus, many research efforts are aimed at searching for the resolution or reduction of such problems. Taking advantage of zebrafish embryos, a powerful model for predicting and translating what is observed in humans, we investigated the plain PTX outcomes and compared them to the effects of different liposomes loaded with PTX. Since approximately 70% of human genes have at least one orthologue in zebrafish, studying the molecular mechanisms underlying chemotherapy-induced toxicity and increased oxidative stress becomes easy. First, we used a transgenic model to evaluate the systemic response to different concentrations of PTX, planning the final concentration to be loaded in liposomes, with and without functionalization. Then, we assessed the effects of this promising nanocarrier system at a molecular, histochemical, and behavioral level in reducing the detrimental side effects of the most successful cancer drug.https://doi.org/10.1038/s41598-025-00258-1Transgenic zebrafish embryosLiposome nanocarrier systemPaclitaxelTherapeutic strategy |
| spellingShingle | Andrea Persico Laura Molteni Paride Mantecca Marcelo Kravicz Cinzia Bragato Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system Scientific Reports Transgenic zebrafish embryos Liposome nanocarrier system Paclitaxel Therapeutic strategy |
| title | Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system |
| title_full | Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system |
| title_fullStr | Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system |
| title_full_unstemmed | Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system |
| title_short | Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system |
| title_sort | transgenic zebrafish embryos to evaluate the in vivo effects of different liposome paclitaxel nanocarrier system |
| topic | Transgenic zebrafish embryos Liposome nanocarrier system Paclitaxel Therapeutic strategy |
| url | https://doi.org/10.1038/s41598-025-00258-1 |
| work_keys_str_mv | AT andreapersico transgeniczebrafishembryostoevaluatetheinvivoeffectsofdifferentliposomepaclitaxelnanocarriersystem AT lauramolteni transgeniczebrafishembryostoevaluatetheinvivoeffectsofdifferentliposomepaclitaxelnanocarriersystem AT paridemantecca transgeniczebrafishembryostoevaluatetheinvivoeffectsofdifferentliposomepaclitaxelnanocarriersystem AT marcelokravicz transgeniczebrafishembryostoevaluatetheinvivoeffectsofdifferentliposomepaclitaxelnanocarriersystem AT cinziabragato transgeniczebrafishembryostoevaluatetheinvivoeffectsofdifferentliposomepaclitaxelnanocarriersystem |